© 2018 by Cardiac Revival Machines
Resources
Benefits of ICD
Long-Term benefit of Primary Prevention with an implantable Cardioverter-Defibrillator
Our findings demonstrate a sustained 8-year survival benefit with primary ICD therapy in the MADIT-II
population.
ICD Longevity
ICD Manufacturers Must Increase Battery Life to Cut Cost , Improve Care
Historically, ICD and CRT-D devices have needed to be replaced every three to seven years as the device's
battery life deteriorates. Consequently, it is not unusual for patients to require several device
replacements over their lifetime meaning additional costly procedures and increased risk of complications
with each procedure. As the baby boomer population in the United States continues to age, and the
average life expectancy in the United States increases to 76 years for men and 81 years for women, the
number of patients who would benefit from a CRM device will grow exponentially. For the average patient
whose CRT-D or ICD device lasts three to five years, this could result in two to four device charge-outs
over their lifetime.
Effect of Battery Longevity on Costs and Health Outcomes Associated with Cardiac Implantable Electronic
Devices
Based on modeling results, as battery longevity increases, patients experience fewer adverse outcomes
and healthcare costs are reduced.
Longevity of Implantable Cardioverter Defibrillators: Implications for Clinical Practice and Health Care Systems
ICD longevity is the priority with respect to size not only for health systems, but also for the patients
themselves.
Longevity of Implantable Cardioverter Defibrillators, Influencing Factors, and Comparison to Industry-Projected
Longevity
Overall, ICD longevity is not quite satisfactory, as even the manufacturer with the best longevity barely
reaches a median longevity of 7.5 years. Industry-projected longevity is an overestimation and does not
accurately reflect real world longevity. Device companies and their engineers should concentrate all their
efforts to improving battery performance. Based on limited experience with selected models, physicians
know that longevity greater than 10 years is technically feasible.
Impact of ICD Battery Longevity on Need for Device Replacements - Insight from a Veterans Affairs Database
Increasing ICD longevity is an important target that will help to reduce patient risks related to
replacements as well as to reduce costs.
Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up
.
Complications from advisory ICD generator replacement are frequent and include infection and, rarely,
death. The risk of replacement is increased in patients with multiple previous pocket procedures.
Mission
Management
Clinical Advisory Board
CRM-1
EMG Needles
© Copyright 2018 by Cardiac Revival Machines
Resources
Benefits of ICD
Long-Term benefit of Primary Prevention with an
implantable Cardioverter-Defibrillator
Our findings demonstrate a sustained 8-year
survival benefit with primary ICD therapy in
the MADIT-II population.
ICD Longevity
ICD Manufacturers Must Increase Battery Life to
Cut Cost , Improve Care
Historically, ICD and CRT-D devices have
needed to be replaced every three to seven
years as the device's battery life deteriorates.
Consequently, it is not unusual for patients to
require several device replacements over their
lifetime meaning additional costly procedures
and increased risk of complications with each
procedure. As the baby boomer population in
the United States continues to age, and the
average life expectancy in the United States
increases to 76 years for men and 81 years for
women, the number of patients who would
benefit from a CRM device will grow
exponentially. For the average patient whose
CRT-D or ICD device lasts three to five years,
this could result in two to four device charge-
outs over their lifetime.
Effect of Battery Longevity on Costs and Health
Outcomes Associated with Cardiac Implantable
Electronic Devices
Based on modeling results, as battery
longevity increases, patients experience fewer
adverse outcomes and healthcare costs are
reduced.
Longevity of Implantable Cardioverter
Defibrillators: Implications for Clinical Practice and
Health Care Systems
ICD longevity is the priority with respect to size
not only for health systems, but also for the
patients themselves.
Longevity of Implantable Cardioverter
Defibrillators, Influencing Factors, and Comparison
to Industry-Projected Longevity
Overall, ICD longevity is not quite satisfactory,
as even the manufacturer with the best
longevity barely reaches a median longevity of
7.5 years. Industry-projected longevity is an
overestimation and does not accurately reflect
real world longevity. Device companies and
their engineers should concentrate all their
efforts to improving battery performance.
Based on limited experience with selected
models, physicians know that longevity
greater than 10 years is technically feasible.
Impact of ICD Battery Longevity on Need for
Device Replacements - Insight from a Veterans
Affairs Database
Increasing ICD longevity is an important target
that will help to reduce patient risks related to
replacements as well as to reduce costs.
Outcome of advisory implantable cardioverter-
defibrillator replacement: one-year follow-up
.
Complications from advisory ICD generator
replacement are frequent and include
infection and, rarely, death. The risk of
replacement is increased in patients with
multiple previous pocket procedures.
Home
About
Mission
Management
Clinical advisory
Products
CRM-1
EMG Needles
Resources
Faq
Contact
needles